Article(id=1329913945181238153, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913887060766847, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2018.08.012, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1526313600000, receivedDateStr=2018-05-15, revisedDate=1528646400000, revisedDateStr=2018-06-11, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005793137, onlineDateStr=2026-11-18, pubDate=1533830400000, pubDateStr=2018-08-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005793137, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005793137, creator=13701087609, updateTime=1795005793137, updator=13701087609, issue=Issue{id=1329913887060766847, tenantId=1146029695717560320, journalId=1319690329412173987, year='2018', volume='39', issue='8', pageStart='S31', pageEnd='576', issueExtLink='null', onlineDate='null', pubDate='1533830400000', pubDateStr='2018-08-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005779280, creator='13701087609', updateTime=1795056509812, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330126666703156144, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913887060766847, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330126666703156145, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329913887060766847, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=563, endPage=568, ext={EN=ArticleExt(id=1329913945378370442, articleId=1329913945181238153, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Advances of biomarkers for cognitive impairment in Parkinson's disease, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Cognitive impairment is the most frequent non-motor symptoms of Parkinson's disease (PD). Around 30% of the patients with PD experience mild cognitive impairment (MCI), which is a high risk factor for the development of dementia. The identification of biomarkers associated with dementia would allow the early diagnosis and intervention of individuals at high risk for dementia. This review summarizes the research progress on the potential biomarkers assessed dementia and MCI in PD patients.

, authors=Yun-yun ZHENG, Yu-hui WANG*, authorsList=Yun-yun ZHENG, Yu-hui WANG, authorCompany=null, correspAuthors=Yu-hui WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329913945663583115, articleId=1329913945181238153, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=帕金森病认知功能障碍生物标志物的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

认知功能障碍是帕金森病(PD)最常见的一种致残性非运动症状,约30%的PD患者表现为轻度认知功能障碍(MCI),是痴呆的高危因素。确定与认知功能障碍相关的生物标志物有助于对痴呆高危人群的早期识别与干预。本文综述帕金森病痴呆和PD-MCI生物标志物的研究进展。

, authors=郑赟赟, 王宇卉*, authorsList=郑赟赟, 王宇卉, authorCompany=null, correspAuthors=王宇卉, authorNote=

郑赟赟,主治医师,研究方向为脑血管病及认知功能障碍。

, correspAuthorsNote=
王宇卉,科主任,主任医师,硕士生导师,研究方向为脑血管病及其他神经疾病。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=VYyjlGO463MTriXkjVGDJQ==, magXml=tlX+9GLAS4PvRrDFYpk4fQ==, pdfUrl=null, pdf=urCmui6ZdH363LK1j7rGkA==, pdfFileSize=1101795, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=KC4WjzIwm3v805cCyCSn/A==, mapNumber=null, fund=null)}, authors=[Author(id=1329913945948795792, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329913946032681874, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, authorId=1329913945948795792, language=EN, stringName=Yun-yun ZHENG, firstName=Yun-yun, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913946103985043, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, authorId=1329913945948795792, language=CN, stringName=郑赟赟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海市浦东新区浦南医院神经内科,上海 200125, bio={"content":"

郑赟赟,主治医师,研究方向为脑血管病及认知功能障碍。

"}, bioImg=null, bioContent=

郑赟赟,主治医师,研究方向为脑血管病及认知功能障碍。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913945869104012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, xref=null, ext=[AuthorCompanyExt(id=1329913945877492621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, companyId=1329913945869104012, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China), AuthorCompanyExt(id=1329913945885881230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, companyId=1329913945869104012, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海市浦东新区浦南医院神经内科,上海 200125)])]), Author(id=1329913946171093909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329913946246591383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, authorId=1329913946171093909, language=EN, stringName=Yu-hui WANG, firstName=Yu-hui, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913946317894552, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, authorId=1329913946171093909, language=CN, stringName=王宇卉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海市浦东新区浦南医院神经内科,上海 200125, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913945869104012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, xref=null, ext=[AuthorCompanyExt(id=1329913945877492621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, companyId=1329913945869104012, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China), AuthorCompanyExt(id=1329913945885881230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, companyId=1329913945869104012, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海市浦东新区浦南医院神经内科,上海 200125)])])], keywords=[Keyword(id=1329913946418557849, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, language=EN, orderNo=1, keyword=Parkinson's disease (PD)), Keyword(id=1329913946485666714, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, language=EN, orderNo=2, keyword=mild cognitive impairment (MCI)), Keyword(id=1329913946556969883, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, language=EN, orderNo=3, keyword=Parkinson's disease dementia (PDD)), Keyword(id=1329913946624078748, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, language=EN, orderNo=4, keyword=biomarker), Keyword(id=1329913946754102173, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, language=CN, orderNo=1, keyword=帕金森病(PD)), Keyword(id=1329913946821211038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, language=CN, orderNo=2, keyword=轻度功能障碍(MCI)), Keyword(id=1329913946884125599, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, language=CN, orderNo=3, keyword=帕金森病痴呆(PDD)), Keyword(id=1329913946947040160, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, language=CN, orderNo=4, keyword=生物标志物)], refs=[Reference(id=1329913947135783842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Papagno C, Trojano L. Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments[J]. Neurol Sci, 2018, 39(2): 215-223., articleTitle=null, refAbstract=null), Reference(id=1329913947198698403, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years[J]. Mov Disord, 2008, 23(6): 837-844., articleTitle=null, refAbstract=null), Reference(id=1329913947261612964, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Savica R, Grossardt BR, Bower JH, et al. Incidence of dementia with Lewy bodies and Parkinson disease dementia[J]. J Am Med Assoc Neurol, 2013, 70(11): 1396-1402., articleTitle=null, refAbstract=null), Reference(id=1329913947324527525, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Litvan I, Aarsland D, Adler CH, et al. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI[J]. Mov Disord, 2011, 26(10): 1814-1824., articleTitle=null, refAbstract=null), Reference(id=1329913947391636390, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Gasca-Salas C, Estanga A, Clavero P, et al. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's Disease[J]. J Parkinson's Dis, 2014, 4(4): 677-686., articleTitle=null, refAbstract=null), Reference(id=1329913947458745255, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Pedersen KF, Larsen JP, Tysnes OB, et al. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study[J]. J Am Med Assoc Neurol, 2013, 70(5): 580-586., articleTitle=null, refAbstract=null), Reference(id=1329913947517465512, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Fengler S, Liepelt-Scarfone I, Brockmann K, et al. Cognitive changes in prodromal Parkinson's disease: a review[J]. Mov Disord, 2017, 32(12): 1655-1666., articleTitle=null, refAbstract=null), Reference(id=1329913947580380073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Aarsland D, Creese B, Politis M, et al. Cognitive decline in Parkinson disease[J]. Nat Rev Neurol, 2017, 13(4): 217-231., articleTitle=null, refAbstract=null), Reference(id=1329913947634906026, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, et al. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease[J]. Mov Disord, 2016, 31(6): 861-881., articleTitle=null, refAbstract=null), Reference(id=1329913947697820587, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Williams-Gray CH, Goris A, Saiki M, et al. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s disease[J]. J Neurol, 2009, 256(3): 493-498., articleTitle=null, refAbstract=null), Reference(id=1329913947756540844, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Morley JF, Xie SX, Hurtig HI, et al. Genetic influences on cognitive decline in Parkinson's disease[J]. Mov Disord, 2012, 27(4): 512-518., articleTitle=null, refAbstract=null), Reference(id=1329913947811066797, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Seto-Salvia N, Clarimon J, Pagonabarraga J, et al. Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes[J]. Arch Neurol, 2011, 68(3): 359-364., articleTitle=null, refAbstract=null), Reference(id=1329913947878175662, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Winder-Rhodes SE, Hampshire A, Rowe JB, et al. Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals[J]. Neurobiol Aging, 2015, 36(3): 1519-1528., articleTitle=null, refAbstract=null), Reference(id=1329913947953673135, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Mata IF, Leverenz JB, Weintraub D, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease[J]. J Am Med Assoc Neurol, 2014, 71(11): 1405-1412., articleTitle=null, refAbstract=null), Reference(id=1329913948029170608, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Brockmann K, Srulijes K, Pflederer S, et al. GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study[J]. Mov Disord, 2015, 30(3): 407-411., articleTitle=null, refAbstract=null), Reference(id=1329913948104668081, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Siderowf A, Aarsland D, Mollenhauer B, et al. Biomarkers for cognitive impairment in Lewy body disorders: status and relevance for clinical trials[J]. Mov Disord, 2018, 33(4): 528-536., articleTitle=null, refAbstract=null), Reference(id=1329913948175971250, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Alves G, Lange J, Blennow K, et al. CSF Abeta42 predicts earlyonset dementia in Parkinson disease[J]. Neurology, 2014, 82(20): 1784-1790., articleTitle=null, refAbstract=null), Reference(id=1329913948251468723, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Parnetti L, Tiraboschi P, Lanari A, et al. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies[J]. Biol Psychiatry, 2008, 64(3): 850-855., articleTitle=null, refAbstract=null), Reference(id=1329913948326966196, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Compta Y, Valente T, Saura J, et al. Correlates of cerebrospinal fluid levels of oligomeric and total-a-synuclein in premotor, motor and dementia stages of Parkinson's disease[J]. J Neurol, 2015, 262(4): 294-306., articleTitle=null, refAbstract=null), Reference(id=1329913948394075061, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Song IU, Kim JS, Park IS, et al. Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD)[J]. Arch Gerontol Geriatr, 2013, 57(3): 288-291., articleTitle=null, refAbstract=null), Reference(id=1329913948456989622, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Annanmaki T, Pessala-Driver A, Hokkanen L, et al. Uric acid associates with cognition in Parkinson's disease[J]. Parkinsonism Relat Disord, 2008, 14(7): 576-578., articleTitle=null, refAbstract=null), Reference(id=1329913948519904183, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Li Z, Zhang J, Sun H. Increased plasma levels of phospholipid in Parkinson's disease with mild cognitive impairment[J]. J Clin Neurosci, 2015, 22(8): 1268-1271., articleTitle=null, refAbstract=null), Reference(id=1329913948587013048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Mielke MM, Maetzler W, Haughey NJ, et al. Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson’s disease and associated with cognitive impairment: a pilot study[J]. PLoS One, 2013, 8(9): e73094-e73094., articleTitle=null, refAbstract=null), Reference(id=1329913948649927609, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Siderowf A, Pontecorvo MJ, Shill HA, et al. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders[J]. Bio Med Central Neurol, 2014, 14(1): 79-79., articleTitle=null, refAbstract=null), Reference(id=1329913948733813690, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Shimada H, Hirano S, Shinotoh H, et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET[J]. Neurology, 2009, 73(4): 273-278., articleTitle=null, refAbstract=null), Reference(id=1329913948792533947, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Klein JC, Eggers C, Kalbe E, et al. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo[J]. Neurology, 2010, 74(11): 885-892., articleTitle=null, refAbstract=null), Reference(id=1329913948855448508, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Akhtar RS, Xie SX, Brennan L, et al. Amyloid-beta positron emission tomography imaging of Alzheimer's pathology in Parkinson's disease dementia[J]. Mov Disord Clin Pract, 2016, 3(4): 367-375., articleTitle=null, refAbstract=null), Reference(id=1329913948922557373, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Donagby P, Thomas AJ, O'Brien JT. Amyloid PET imaging in Lewy body disorders[J]. Am J Geriatr Psychiatry, 2015, 23(1): 23-37., articleTitle=null, refAbstract=null), Reference(id=1329913948981277630, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Pontecorvo MJ, Devous MD Sr, Navitsky M, et al. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition[J]. Brain, 2017, 140(3): 748-763., articleTitle=null, refAbstract=null), Reference(id=1329913949056775103, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Kantarci K, Lowe VJ, Boeve BF, et al. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies[J]. Ann Neurol, 2017, 81(1): 58-67., articleTitle=null, refAbstract=null), Reference(id=1329913949111301056, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Duncan GW, Firbank MJ, Yarnall AJ, et al. Gray and white matter imaging: a biomarker for cognitive impairment in early Parkinson’s disease?[J]. Mov Disord, 2016, 31(1): 103-110., articleTitle=null, refAbstract=null), Reference(id=1329913949182604225, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Mak E, Su L, Williams GB, et al. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLEPD study[J]. Brain, 2015, 138(Pt 10): 2974-2986., articleTitle=null, refAbstract=null), Reference(id=1329913949245518786, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Goldman JG, Bledsoe IO, Merkitch D, et al. Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease[J]. Neurology, 2017, 88(13): 1265-1272., articleTitle=null, refAbstract=null), Reference(id=1329913949300044739, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Compta Y, Buongiorno M, Bargallo N, et al. White matter hyperintensities, cerebrospinal amyloid-beta and dementia in Parkinson’s disease[J]. J Neurol Sci, 2016, 367: 284-290., articleTitle=null, refAbstract=null), Reference(id=1329913949358764996, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Melzer TR, Watts R, MacAskill MR, et al. White matter microstructure deteriorates across cognitive stages in Parkinson disease[J]. Neurology, 2013, 80(20): 1841-1849., articleTitle=null, refAbstract=null), Reference(id=1329913949421679557, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Hattori T, Orimo S, Aoki S, et al. Cognitive status correlates with white matter alteration in Parkinson's disease[J]. Hum Brain Mapp, 2012, 33(3): 727-739., articleTitle=null, refAbstract=null), Reference(id=1329913949488788422, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Nie K, Zhang Y, Huang B, et al. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment[J]. Parkinsonism Relat Disord, 2013, 19(3): 329-334., articleTitle=null, refAbstract=null), Reference(id=1329913949547508679, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Garcia-Garcia D, Clavero P, Gasca Salas C, et al. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease[J]. Eur J Nucl Med Mol Imaging, 2012, 39(11): 1767-1777., articleTitle=null, refAbstract=null), Reference(id=1329913949610423240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Ekman U, Eriksson J, Forsgren L, et al. Longitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment[J]. Front Neurosci, 2014, 8: 207-207., articleTitle=null, refAbstract=null), Reference(id=1329913949685920713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Babiloni C, Del Percio C, Lizio R, et al. Abnormalities of cortical neural synchronization mechanisms in subjects with mild cognitive impairment due to Alzheimer's and Parkinson's diseases: an EEG study[J]. J Alzheimers Dis, 2017, 59(1): 339-358., articleTitle=null, refAbstract=null), Reference(id=1329913949740446666, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Bonanni L, Perfetti B, Bifolchetti S, et al. Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies[J]. Neurobiol Aging, 2015, 36(1): 434-445., articleTitle=null, refAbstract=null), Reference(id=1329913949803361227, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Bosboom JL, Stoffers D, Wolters E, et al. MEG resting state functional connectivity in Parkinson's disease related dementia[J]. J Neural Transm, 2009, 116(2): 193-202., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329913947043509153, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, awardId=PKJ2014-Y27, language=CN, fundingSource=上海市浦东新区科技发展基金项目(PKJ2014-Y27), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329913945869104012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, xref=null, ext=[AuthorCompanyExt(id=1329913945877492621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, companyId=1329913945869104012, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China), AuthorCompanyExt(id=1329913945885881230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, companyId=1329913945869104012, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海市浦东新区浦南医院神经内科,上海 200125)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.08.012, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.08.012, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2018.08.012, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2018.08.012, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1533830400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
帕金森病认知功能障碍生物标志物的研究进展
郑赟赟 , 王宇卉 *
世界临床药物 | 综述评论 2018,39(8): 563-568
收起
收藏切换
世界临床药物 |综述评论 2018 , 39 (8) : 563 -568
帕金森病认知功能障碍生物标志物的研究进展
全屏
[Author(id=1329913945948795792, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329913946032681874, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, authorId=1329913945948795792, language=EN, stringName=Yun-yun ZHENG, firstName=Yun-yun, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913946103985043, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, authorId=1329913945948795792, language=CN, stringName=郑赟赟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海市浦东新区浦南医院神经内科,上海 200125, bio={"content":"

郑赟赟,主治医师,研究方向为脑血管病及认知功能障碍。

"}, bioImg=null, bioContent=

郑赟赟,主治医师,研究方向为脑血管病及认知功能障碍。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913945869104012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, xref=null, ext=[AuthorCompanyExt(id=1329913945877492621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, companyId=1329913945869104012, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China), AuthorCompanyExt(id=1329913945885881230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, companyId=1329913945869104012, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海市浦东新区浦南医院神经内科,上海 200125)])]), Author(id=1329913946171093909, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329913946246591383, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, authorId=1329913946171093909, language=EN, stringName=Yu-hui WANG, firstName=Yu-hui, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329913946317894552, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, authorId=1329913946171093909, language=CN, stringName=王宇卉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海市浦东新区浦南医院神经内科,上海 200125, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329913945869104012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, xref=null, ext=[AuthorCompanyExt(id=1329913945877492621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, companyId=1329913945869104012, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China), AuthorCompanyExt(id=1329913945885881230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329913945181238153, companyId=1329913945869104012, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海市浦东新区浦南医院神经内科,上海 200125)])])]
郑赟赟, 王宇卉*
作者信息
  • 上海市浦东新区浦南医院神经内科,上海 200125
通讯作者:
王宇卉,科主任,主任医师,硕士生导师,研究方向为脑血管病及其他神经疾病。
作者简介:

郑赟赟,主治医师,研究方向为脑血管病及认知功能障碍。

Advances of biomarkers for cognitive impairment in Parkinson's disease
Yun-yun ZHENG, Yu-hui WANG*
Affiliations
  • Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China
出版时间: 2018-08-10 doi: 10.13683/j.wph.2018.08.012
文章导航
收藏切换

认知功能障碍是帕金森病(PD)最常见的一种致残性非运动症状,约30%的PD患者表现为轻度认知功能障碍(MCI),是痴呆的高危因素。确定与认知功能障碍相关的生物标志物有助于对痴呆高危人群的早期识别与干预。本文综述帕金森病痴呆和PD-MCI生物标志物的研究进展。

帕金森病(PD)  /  轻度功能障碍(MCI)  /  帕金森病痴呆(PDD)  /  生物标志物

Cognitive impairment is the most frequent non-motor symptoms of Parkinson's disease (PD). Around 30% of the patients with PD experience mild cognitive impairment (MCI), which is a high risk factor for the development of dementia. The identification of biomarkers associated with dementia would allow the early diagnosis and intervention of individuals at high risk for dementia. This review summarizes the research progress on the potential biomarkers assessed dementia and MCI in PD patients.

Parkinson's disease (PD)  /  mild cognitive impairment (MCI)  /  Parkinson's disease dementia (PDD)  /  biomarker
郑赟赟, 王宇卉. 帕金森病认知功能障碍生物标志物的研究进展. 世界临床药物, 2018 , 39 (8) : 563 -568 . DOI: 10.13683/j.wph.2018.08.012
Yun-yun ZHENG, Yu-hui WANG. Advances of biomarkers for cognitive impairment in Parkinson's disease[J]. World Clinical Drug, 2018 , 39 (8) : 563 -568 . DOI: 10.13683/j.wph.2018.08.012
  • 上海市浦东新区科技发展基金项目(PKJ2014-Y27)
参考文献 引证文献
排序方式:
[1]
Papagno C, Trojano L. Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments[J]. Neurol Sci, 2018, 39(2): 215-223.
[2]
Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years[J]. Mov Disord, 2008, 23(6): 837-844.
[3]
Savica R, Grossardt BR, Bower JH, et al. Incidence of dementia with Lewy bodies and Parkinson disease dementia[J]. J Am Med Assoc Neurol, 2013, 70(11): 1396-1402.
[4]
Litvan I, Aarsland D, Adler CH, et al. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI[J]. Mov Disord, 2011, 26(10): 1814-1824.
[5]
Gasca-Salas C, Estanga A, Clavero P, et al. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's Disease[J]. J Parkinson's Dis, 2014, 4(4): 677-686.
[6]
Pedersen KF, Larsen JP, Tysnes OB, et al. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study[J]. J Am Med Assoc Neurol, 2013, 70(5): 580-586.
[7]
Fengler S, Liepelt-Scarfone I, Brockmann K, et al. Cognitive changes in prodromal Parkinson's disease: a review[J]. Mov Disord, 2017, 32(12): 1655-1666.
[8]
Aarsland D, Creese B, Politis M, et al. Cognitive decline in Parkinson disease[J]. Nat Rev Neurol, 2017, 13(4): 217-231.
[9]
Delgado-Alvarado M, Gago B, Navalpotro-Gomez I, et al. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease[J]. Mov Disord, 2016, 31(6): 861-881.
[10]
Williams-Gray CH, Goris A, Saiki M, et al. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s disease[J]. J Neurol, 2009, 256(3): 493-498.
[11]
Morley JF, Xie SX, Hurtig HI, et al. Genetic influences on cognitive decline in Parkinson's disease[J]. Mov Disord, 2012, 27(4): 512-518.
[12]
Seto-Salvia N, Clarimon J, Pagonabarraga J, et al. Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes[J]. Arch Neurol, 2011, 68(3): 359-364.
[13]
Winder-Rhodes SE, Hampshire A, Rowe JB, et al. Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals[J]. Neurobiol Aging, 2015, 36(3): 1519-1528.
[14]
Mata IF, Leverenz JB, Weintraub D, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease[J]. J Am Med Assoc Neurol, 2014, 71(11): 1405-1412.
[15]
Brockmann K, Srulijes K, Pflederer S, et al. GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study[J]. Mov Disord, 2015, 30(3): 407-411.
[16]
Siderowf A, Aarsland D, Mollenhauer B, et al. Biomarkers for cognitive impairment in Lewy body disorders: status and relevance for clinical trials[J]. Mov Disord, 2018, 33(4): 528-536.
[17]
Alves G, Lange J, Blennow K, et al. CSF Abeta42 predicts earlyonset dementia in Parkinson disease[J]. Neurology, 2014, 82(20): 1784-1790.
[18]
Parnetti L, Tiraboschi P, Lanari A, et al. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies[J]. Biol Psychiatry, 2008, 64(3): 850-855.
[19]
Compta Y, Valente T, Saura J, et al. Correlates of cerebrospinal fluid levels of oligomeric and total-a-synuclein in premotor, motor and dementia stages of Parkinson's disease[J]. J Neurol, 2015, 262(4): 294-306.
[20]
Song IU, Kim JS, Park IS, et al. Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD)[J]. Arch Gerontol Geriatr, 2013, 57(3): 288-291.
[21]
Annanmaki T, Pessala-Driver A, Hokkanen L, et al. Uric acid associates with cognition in Parkinson's disease[J]. Parkinsonism Relat Disord, 2008, 14(7): 576-578.
[22]
Li Z, Zhang J, Sun H. Increased plasma levels of phospholipid in Parkinson's disease with mild cognitive impairment[J]. J Clin Neurosci, 2015, 22(8): 1268-1271.
[23]
Mielke MM, Maetzler W, Haughey NJ, et al. Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson’s disease and associated with cognitive impairment: a pilot study[J]. PLoS One, 2013, 8(9): e73094-e73094.
[24]
Siderowf A, Pontecorvo MJ, Shill HA, et al. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders[J]. Bio Med Central Neurol, 2014, 14(1): 79-79.
[25]
Shimada H, Hirano S, Shinotoh H, et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET[J]. Neurology, 2009, 73(4): 273-278.
[26]
Klein JC, Eggers C, Kalbe E, et al. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo[J]. Neurology, 2010, 74(11): 885-892.
[27]
Akhtar RS, Xie SX, Brennan L, et al. Amyloid-beta positron emission tomography imaging of Alzheimer's pathology in Parkinson's disease dementia[J]. Mov Disord Clin Pract, 2016, 3(4): 367-375.
[28]
Donagby P, Thomas AJ, O'Brien JT. Amyloid PET imaging in Lewy body disorders[J]. Am J Geriatr Psychiatry, 2015, 23(1): 23-37.
[29]
Pontecorvo MJ, Devous MD Sr, Navitsky M, et al. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition[J]. Brain, 2017, 140(3): 748-763.
[30]
Kantarci K, Lowe VJ, Boeve BF, et al. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies[J]. Ann Neurol, 2017, 81(1): 58-67.
[31]
Duncan GW, Firbank MJ, Yarnall AJ, et al. Gray and white matter imaging: a biomarker for cognitive impairment in early Parkinson’s disease?[J]. Mov Disord, 2016, 31(1): 103-110.
[32]
Mak E, Su L, Williams GB, et al. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLEPD study[J]. Brain, 2015, 138(Pt 10): 2974-2986.
[33]
Goldman JG, Bledsoe IO, Merkitch D, et al. Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease[J]. Neurology, 2017, 88(13): 1265-1272.
[34]
Compta Y, Buongiorno M, Bargallo N, et al. White matter hyperintensities, cerebrospinal amyloid-beta and dementia in Parkinson’s disease[J]. J Neurol Sci, 2016, 367: 284-290.
[35]
Melzer TR, Watts R, MacAskill MR, et al. White matter microstructure deteriorates across cognitive stages in Parkinson disease[J]. Neurology, 2013, 80(20): 1841-1849.
[36]
Hattori T, Orimo S, Aoki S, et al. Cognitive status correlates with white matter alteration in Parkinson's disease[J]. Hum Brain Mapp, 2012, 33(3): 727-739.
[37]
Nie K, Zhang Y, Huang B, et al. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment[J]. Parkinsonism Relat Disord, 2013, 19(3): 329-334.
[38]
Garcia-Garcia D, Clavero P, Gasca Salas C, et al. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease[J]. Eur J Nucl Med Mol Imaging, 2012, 39(11): 1767-1777.
[39]
Ekman U, Eriksson J, Forsgren L, et al. Longitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment[J]. Front Neurosci, 2014, 8: 207-207.
[40]
Babiloni C, Del Percio C, Lizio R, et al. Abnormalities of cortical neural synchronization mechanisms in subjects with mild cognitive impairment due to Alzheimer's and Parkinson's diseases: an EEG study[J]. J Alzheimers Dis, 2017, 59(1): 339-358.
[41]
Bonanni L, Perfetti B, Bifolchetti S, et al. Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies[J]. Neurobiol Aging, 2015, 36(1): 434-445.
[42]
Bosboom JL, Stoffers D, Wolters E, et al. MEG resting state functional connectivity in Parkinson's disease related dementia[J]. J Neural Transm, 2009, 116(2): 193-202.
2018年第39卷第8期
12
4
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2018.08.012
  • 接收时间:2018-05-15
  • 首发时间:2026-11-18
  • 出版时间:2018-08-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2018-05-15
  • 修回日期:2018-06-11
基金
上海市浦东新区科技发展基金项目(PKJ2014-Y27)
作者信息
    上海市浦东新区浦南医院神经内科,上海 200125

通讯作者:

王宇卉,科主任,主任医师,硕士生导师,研究方向为脑血管病及其他神经疾病。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.08.012
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏